The new results helped boost Moderna’s stock by more than 4% in early trading June 30, though the company’s shares are still down about 32% for the year. Moderna has more on the science behind mRNA.

The signers acknowledged that leaders of their professions had previously condemned a street protest against lockdown ...

In a Policy Forum, Erin Sorrell and colleagues – a coalition of virologists, veterinarians, and health security experts – ...